San Diego, April 18 2019 – Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of BlueLoop, a care coordination resource for children with type 1 diabetes. BlueLoop, powered by the non-profit MyCareConnect Foundation, is a tool to help improve a family's ability to manage a child’s diabetes when the child is at school or away from home.
“At Tandem Diabetes Care, we understand the challenges of diabetes management, especially for families,” said John Sheridan, President and CEO at Tandem Diabetes Care. “We are proud to support the MyCareConnect Foundation, to help them bring BlueLoop, to more families impacted by diabetes who are working hard to help their children thrive at home and at school.”
“I created BlueLoop to help communicate with my school nurse after our daughter was diagnosed with type 1 diabetes 16 years ago at age six. Little did I know it would become a resource for thousands of families, schools and endocrinologists,” said Pam Henry, Founder of BlueLoop and the MyCareConnect Foundation. "Our foundation provides BlueLoop free of charge. Tandem’s sponsorship enables us to reach more families in need of better, more effective diabetes care coordination.”
BlueLoop® is an online and mobile solution for children with diabetes and their parents who worry. BlueLoop provides care coordination among caregivers, improving a child's and family's ability to manage diabetes, especially when the child is at school or away from home. BlueLoop uses instant notifications via email/text to keep caregivers – parents, nurses, teachers, etc. – informed. Caregivers can also put information like BGs, carbs, insulin, and notes into their child's account. BlueLoop also documents current dosages, and is an effective way to collaborate with your Endocrinologist. BlueLoop is available online and as a mobile app.
Tandem Diabetes Care periodically provides sponsorships and grants for educational and empowerment programing in the diabetes community. Grants are awarded to qualified non-profit organizations with the mission to empower people with diabetes, and to assist local initiatives, events, and programing that support Tandem’s mission, its employees, and corporate citizenship.
A 501(c)3 based in Dallas, Texas, MyCareConnect’s mission is to support the physical and emotional well-being of children with diabetes, and those who care for them, by facilitating communication among home, school and clinic. blueloop.mycareconnect.com
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ Insulin Pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.
Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc. All other third-party marks are the property of their respective owners.
Tandem Diabetes Care Contact Information:
Media: Steve Sabicer, 714-907-6264, firstname.lastname@example.org
Investors: Susan Morrison, 858-366-6900 x7005, IR@tandemdiabetes.com
# # #